CYP2C9*1B Promoter Polymorphisms, in Linkage with CYP2C19*2, Affect Phenytoin Autoinduction of Clearance and Maintenance Dose
Year: 2009
Type: article
Institutions: University of Minnesota, St. Jude Children's Research Hospital, University of Pittsburgh, Duke University, Chinese University of Hong Kong, University of Minnesota System, Duke Medical Center, National Hospital for Neurology and Neurosurgery, UCL Queen Square Institute of Neurology, University College London
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: bronze
Funders: American Epilepsy Society, Wellcome Trust, American Lebanese Syrian Associated Charities, NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research, National Institute for Health and Care Research, University College London, Chinese University of Hong Kong, Epilepsy Society, National Institutes of Health, Medical Research Council, National Cancer Institute, National Institute of General Medical Sciences, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Neurological Disorders and Stroke
Awards: G1125664328, G249297184, Genome-wide association studies in partial epilepsies., G4277768125, G4699402445, G593039475, G609259107, G621298182, PAAR-Pharmacogenomics of Anticancer Agents Research Group, G8481610704, G865138149, G9000054255, G9000086855, G9000201772, Cancer Center Support Grant (CCSG), G925486714, Epilepsy Clinical Research Program
OpenAlex ID: W2157170286